201 related articles for article (PubMed ID: 19522849)
1. MCM 2 Expression in Basal Cell Carcinomas and Trichoepitheliomas.
Liaw K; Boyd AS
J Cutan Pathol; 2009 Oct; 36(10):1121-2. PubMed ID: 19522849
[No Abstract] [Full Text] [Related]
2. Immunolabeling pattern of podoplanin (d2-40) may distinguish basal cell carcinomas from trichoepitheliomas: a clinicopathologic and immunohistochemical study of 49 cases.
Plaza JA; Ortega PF; Bengana C; Stockman DL; Suster S
Am J Dermatopathol; 2010 Oct; 32(7):683-7. PubMed ID: 20559122
[TBL] [Abstract][Full Text] [Related]
3. Follicular stem cell marker PHLDA1 (TDAG51) is superior to cytokeratin-20 in differentiating between trichoepithelioma and basal cell carcinoma in small biopsy specimens.
Sellheyer K; Nelson P
J Cutan Pathol; 2011 Jul; 38(7):542-50. PubMed ID: 21352265
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibody Ber-EP4 reliably discriminates between microcystic adnexal carcinoma and basal cell carcinoma.
Krahl D; Sellheyer K
J Cutan Pathol; 2007 Oct; 34(10):782-7. PubMed ID: 17880584
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical analysis of laminin 5-γ2 chain expression for differentiation of basal cell carcinoma from trichoblastoma.
Hamasaki H; Koga K; Hamasaki M; Kiryu H; Nakayama J; Iwasaki H; Nabeshima K
Histopathology; 2011 Jul; 59(1):159-61. PubMed ID: 21771037
[No Abstract] [Full Text] [Related]
6. Expression of S100A6 protein in a broad spectrum of cutaneous tumors using tissue microarrays.
Fullen DR; Garrisi AJ; Sanders D; Thomas D
J Cutan Pathol; 2008 Nov; 35 Suppl 2():28-34. PubMed ID: 18201235
[TBL] [Abstract][Full Text] [Related]
7. Clear-cell basal cell carcinoma: differentiation from other clear-cell tumors.
Forman SB; Ferringer TC
Am J Dermatopathol; 2007 Apr; 29(2):208-9. PubMed ID: 17414450
[No Abstract] [Full Text] [Related]
8. Immunohistochemical expression of D2-40 in benign and malignant sebaceous tumors and comparison to basal and squamous cell carcinomas.
Yang HM; Cabral E; Dadras SS; Cassarino DS
Am J Dermatopathol; 2008 Dec; 30(6):549-54. PubMed ID: 19033927
[TBL] [Abstract][Full Text] [Related]
9. Expression of androgen receptor by fibroepithelioma of Pinkus: evidence supporting classification as a basal cell carcinoma variant?
Katona TM; Ravis SM; Perkins SM; Moores WB; Billings SD
Am J Dermatopathol; 2007 Feb; 29(1):7-12. PubMed ID: 17284955
[TBL] [Abstract][Full Text] [Related]
10. Elastic fiber staining and cytokeratin 15 expression pattern in trichoepithelioma and basal cell carcinoma.
Choi CW; Park HS; Kim YK; Lee SH; Cho KH
J Dermatol; 2008 Aug; 35(8):499-502. PubMed ID: 18789069
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical evaluation of metallothionein, Mcm-2 and Ki-67 antigen expression in tumors of the adrenal cortex.
Szajerka A; Dziegiel P; Szajerka T; Zabel M; Winowski J; Grzebieniak Z
Anticancer Res; 2008; 28(5B):2959-65. PubMed ID: 19031940
[TBL] [Abstract][Full Text] [Related]
12. Sarcomatoid basal cell carcinoma.
Ríos-Martín JJ; González-Cámpora R; Moreno-Ramírez D; Camacho-Martínez F
Am J Dermatopathol; 2005 Dec; 27(6):546; author reply 546. PubMed ID: 16314711
[No Abstract] [Full Text] [Related]
13. SOX9 expression is a general marker of basal cell carcinoma and adnexal-related neoplasms.
Vidal VP; Ortonne N; Schedl A
J Cutan Pathol; 2008 Apr; 35(4):373-9. PubMed ID: 18333897
[TBL] [Abstract][Full Text] [Related]
14. Expression of TPX2 in salivary gland carcinomas.
Shigeishi H; Ohta K; Hiraoka M; Fujimoto S; Minami M; Higashikawa K; Kamata N
Oncol Rep; 2009 Feb; 21(2):341-4. PubMed ID: 19148505
[TBL] [Abstract][Full Text] [Related]
15. Keloidal basal cell carcinoma.
Lewis JE
Am J Dermatopathol; 2007 Oct; 29(5):485. PubMed ID: 17890922
[TBL] [Abstract][Full Text] [Related]
16. Bcl-2 and CD10 expression in the differential diagnosis of trichoblastoma, basal cell carcinoma, and basal cell carcinoma with follicular differentiation.
Córdoba A; Guerrero D; Larrinaga B; Iglesias ME; Arrechea MA; Yanguas JI
Int J Dermatol; 2009 Jul; 48(7):713-7. PubMed ID: 19570076
[TBL] [Abstract][Full Text] [Related]
17. Epidermal basaloid cell hyperplasia overlying dermatofibromas.
Lindboe CF; Løvdal L
Am J Dermatopathol; 2011 Feb; 33(1):52-5. PubMed ID: 21178581
[TBL] [Abstract][Full Text] [Related]
18. Amelanotic malignant melanoma: two collision tumors presenting as basal cell carcinoma and atypical fibroxanthoma.
McGregor DH; Cherian R; Romanas MM; Ulusarac O; Mathur SC; Feldman MM
Ann Clin Lab Sci; 2008; 38(2):157-62. PubMed ID: 18469362
[TBL] [Abstract][Full Text] [Related]
19. Actin and calponin expression in basal cell carcinoma.
Lee MW; Ahn SJ; Choi JH; Moon KC; Koh JK
Br J Dermatol; 2004 Oct; 151(4):934-6. PubMed ID: 15491449
[No Abstract] [Full Text] [Related]
20. Nevoid basal cell carcinoma syndrome or multiple hereditary infundibulocystic basal cell carcinoma syndrome?
Crawford KM; Kobayashi T
J Am Acad Dermatol; 2004 Dec; 51(6):989-95. PubMed ID: 15583598
[TBL] 
